PRPH
ProPhase Labs, Inc.
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Gross Profit
$1.4M
↑ 1022.7%
Operating Income
$-18047000
↑ 53.3%
Net Income
$-14743000
↑ 72.4%
EPS (Diluted)
$-1.74
↑ 33.3%
Shareholders' Equity
$3.5M
↓ 52.3%
Total Liabilities
$56.4M
↑ 0.9%
Cash & Equivalents
$90000.00
↓ 86.7%
Long-term Debt
$2.9M
↑ Infinity%

Recent SEC Filings

Form Type Filed Date Link
10-K 6/1/2026 View on SEC
NT 10-Q 5/15/2026 View on SEC
NT 10-K 3/27/2026 View on SEC
8-K 2/13/2026 View on SEC
8-K 2/13/2026 View on SEC
8-K 1/27/2026 View on SEC
8-K 1/23/2026 View on SEC
8-K 1/23/2026 View on SEC
25-NSE 1/23/2026 View on SEC
8-K 1/9/2026 View on SEC

Company Information

Field Value
Ticker PRPH
Company Name ProPhase Labs, Inc.
CIK 868278
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (215) 345-0919